Monsanto appoints Cherukuri Ravishankar as India MD
Monsanto India, a subsidiary of Bayer group, has appointed Cherukuri Ravishankar as the Managing Director for its businesses in India, Bangladesh and Sri Lanka. This is the first major change in Monsanto India after German pharma and chemical major Bayer AG had in June this year completed the $63 billion mega deal to acquire the US based biotech major Monsanto. Ravishankar will replace Shilpa Divekar Nirula, who now moves on to a senior leadership position at the parent company Bayer. However, she would continue to remain as a non-executive director of the company. Ravishankar, who has earlier been a non-executive director of the company, has been instrumental in conceptualising and implementing strategic initiatives in commercial and modernising supply chain operations of the company. He brings with him 21 years of experience across multiple functions, including commercial, strategy and supply chain.